# Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma

> **NCT02325401** · PHASE1 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 20 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Metformin
- **DRUG:** Cisplatin
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT02325401
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-11
- **Primary completion:** 2017-12-26
- **Final completion:** 2020-02-21
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02325401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02325401, "Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02325401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*